SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-095013
Filing Date
2023-08-24
Accepted
2023-08-24 21:45:30
Documents
2
Period of Report
2023-08-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2324788-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2324788-2_3seq1.xml 3 1568
2 EXHIBIT 24.1 tm2324788d2_ex24-1.htm EX-24.1 9597
  Complete submission text file 0001104659-23-095013.txt   12486
Mailing Address 235 LAUREL LN HAVERFOLD PA 19041
Business Address
BIZZARI JEAN-PIERRE (Reporting) CIK: 0001630914 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39069 | Film No.: 231203684

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations